论文信息 - Osteoporosis and schizophrenia: Can we limit known risk factors? - 字舞流文

Osteoporosis and schizophrenia: Can we limit known risk factors?

J. Leon | G. Abraham | C. Verghese | R. H. Friedman

[1] E. Levin,et al. Clozapine decreases smoking in patients with chronic schizophrenia , 1995, Biological Psychiatry.

[2] G. Simpson,et al. Treatment of Polydipsia and Hyponatremia in Psychiatric Patients , 1995, Neuropsychopharmacology.

[3] G. Simpson,et al. Schizophrenia and smoking: an epidemiological survey in a state hospital. , 1995, The American journal of psychiatry.

[4] D. Jeste,et al. Physical comorbidity and polypharmacy in older psychiatric patients , 1994, Biological Psychiatry.

[5] L. Siever,et al. Clozapine treatment and its effect on neuroendocrine responses induced by the serotonin agonist, m-chlorophenylpiperazine , 1994, Biological Psychiatry.

[6] G. Simpson,et al. Polydipsia and water intoxication in psychiatric patients: A review of the epidemiological literature , 1994, Biological Psychiatry.

[7] J. Owen,et al. Osteopenia, pathological fractures, and increased urinary calcium excretion in schizophrenic patients with polydipsia , 1989, Biological Psychiatry.

[8] A. Klibanski,et al. Osteoporosis in men with hyperprolactinemic hypogonadism. , 1986, Annals of internal medicine.

[9] A. Klibanski,et al. Decreased bone density in hyperprolactinemic women. , 1980, The New England journal of medicine.